Sorrento Therapeutics Inc (SRNE)

[dia76ca]

All I want for Christmas is for one analyst, ANY analyst, to do a serious, comprehensive analysis of Sorrento's entire pipeline! The most recent ignored the $34 million DARPA grant! This opens the door to further DOD and Warpspeed funding...it is big deal!
It also excluded any value to Covi-Drops or SmartPharm applications to Covid or cancer applications. It doesn't mention SP-102 for sciatic pain (phase 3 enrollment complete this month) and excluded any value from RTX for cancer pain. It doesn't refer to the potential ACEA acquisition or assign any value to the Abivirtinib phase 3 NSCLC application. And there is no value assigned to Celularity or to the potential $1 billion PSS lawsuit settlement. It also applied very conservative discount rates.

Maybe 2021 will see some analysts do some serious work...until then their average target of $25 will remain, but I would not be surprised to see that exceeded in January. All that is needed is two or three good EUA approvals! Merry Christmas and a Happy and Healthy New Year to all!